Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: Response Variability in Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 clinical trial update describing variability in response to treatment among children with Attention Deficit Hyperactivity Disorder. …
-
FDA approval · 2012-03-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Teva’s generic combination of four amphetamine salts (dextroamphetamine saccharate, amphetam…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Children and Parents With ADHD and Related Disorders
Completed clinical trial NCT01260792 studying ADHD and related disorders in children and their parents, sponsored by Centre Hospitalier Univ…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17 [Phase 3]
Phase 3 randomized, double-blind safety and efficacy study of lisdexamfetamine dimesylate in children and adolescents with ADHD has complete…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Improving Sleep and Daytime Functioning Among Children Diagnosed With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]
The update notes the completion of Phase 1 and Phase 2 trials evaluating a sleep-improvement intervention for children with ADHD, with resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-03-15FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' methylphenidate hydrochloride as a generic original-application product for the treatment of att…
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]
Phase 3 open-label safety study evaluating chronic exposure to CLONICEL (clonidine hydrochloride sustained-release) in children and adolesce…
-
CLINICAL_TRIALS trial_result · 2012-02-22Clinical Trial Update: Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD) [Phase 2]
A Phase 2 pilot study evaluating dextroamphetamine for treating cocaine dependence in individuals with ADHD has been terminated.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 4]
Phase 4 clinical trial assessing SPD489 for safety and efficacy on executive function behaviors in adults with ADHD and executive function i…
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults [Phase 3]
Phase 3 trial of CONCERTA (OROS methylphenidate hydrochloride) for attention-deficit/hyperactivity disorder in adults has completed.
-
CLINICAL_TRIALS research · 2012-02-10Clinical Trial Update: Executive Function in Learning in Children With Attention Deficit Hyperactivity Disorder (ADHD) Receiving Medical Treatment Alone Compared to Children Receiving Additional Treatment to Improve Learning Strategies
This clinical trial update describes a study in children with Attention-deficit/hyperactivity disorder comparing medical treatment alone to …
-
CLINICAL_TRIALS research · 2012-02-08Clinical Trial Update: ADHD - Voice Analysis, Vocal Acoustic Biomarkers in Attention Deficit Hyperactivity Disorder
Clinical trial update focusing on voice analysis and vocal acoustic biomarkers in attention-deficit/hyperactivity disorder (ADHD).
-
FDA approval · 2012-02-07FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a four-salt amphetamine combination (dextroamphetamine saccharate, amph…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta [Phase 4]
Phase 4 trial evaluating whether Concerta (methylphenidate extended-release) can prevent cigarette smoking initiation in youth with ADHD; re…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory [Phase 4]
Phase 4 clinical trial evaluating the effects of OROS methylphenidate (Concerta) on attention and memory in children with ADHD. The study ha…
-
CLINICAL_TRIALS trial_result · 2011-12-15Clinical Trial Update: Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia [Phase 4]
Phase 4 trial evaluating atomoxetine for treating ADHD in children and adolescents with comorbid dyslexia; results were posted in 2011.
-
FDA approval · 2011-12-01FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved the original application for a generic methylphenidate hydrochloride extended-release product (LA) from Dr. Reddy's Laboratorie…
-
CLINICAL_TRIALS trial_result · 2011-11-29Clinical Trial Update: Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse [Phase 4]
A Phase 4 pilot study of Vyvanse (lisdexamfetamine) in adolescents with ADHD at risk for substance abuse has completed and results are poste…
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: The Reinforcing Mechanisms of Smoking in Adult ADHD [Phase 1, Phase 2]
Phase 1/Phase 2 clinical studies conducted by University of California, Irvine examined the reinforcing mechanisms of smoking in adults with…
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: A Bioequivalence (BE) Study in Healthy Subjects [Phase 1]
This update reports the completion of a Phase 1 bioequivalence study in healthy volunteers evaluating an ADHD drug candidate from Eli Lilly;…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) [Phase 3]
A Phase 3 trial evaluated tolerability and efficacy of AM and PM once-daily extended-release guanfacine hydrochloride for children aged 6-12…
-
FDA approval · 2011-10-25FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved Wilshire Pharmaceuticals' generic dextroamphetamine sulfate under an original ANDA. The product is intended for the same in…
-
CLINICAL_TRIALS trial_result · 2011-10-18Clinical Trial Update: A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
A Phase 2 dose-ranging, cross-over study evaluated the safety and efficacy of ABT-089 in adults with ADHD. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-05Clinical Trial Update: Pharmacogenetic Study of Methylphenidate in Attention Deficit/Hyperactivity Disorder(ADHD) [Phase 4]
A Phase 4 pharmacogenetic study evaluating how genetic factors influence response to methylphenidate in Attention Deficit Hyperactivity Diso…
-
CLINICAL_TRIALS research · 2011-10-05Clinical Trial Update: a Case-control Study of the Association Between Heavy Mental and Children With Attention Deficit Hyperactivity Disorder in Korea
This clinical trial update describes a case-control study examining whether exposure to heavy metals is associated with ADHD in Korean child…